Continuous visual field test supervision may not always be necessary

Ophthalmology

Volumn 106, Issue 1, 1999, Pages 178-181

  Van Coevorden, Rosita E ^a   Mills, Richard P ^a,b   Chen, Ying Ying ^a   Barnebey, Howard S ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; LABORATORY DIAGNOSIS; MONITORING; PERIMETRY; PREDICTION AND FORECASTING; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; STANDARD; VISUAL FIELD;

AGED; CROSS-SECTIONAL STUDIES; FALSE POSITIVE REACTIONS; GLAUCOMA; HUMANS; MONITORING, PHYSIOLOGIC; OCULAR HYPERTENSION; PERIMETRY; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; VISUAL FIELDS;

EID: 0032622530     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)90016-7     Document Type: Article

References (5)

1. Walsh TJ, ed. Visual Fields: Examination and Interpretation, 2nd ed. San Francisco: American Academy of Ophthalmology, 1996;121 (ophthalmology monographs; 3).
2. Anderson DR. Perimetry With and Without Automation, 2nd ed. St. Louis: Mosby, 1987;207.
3. Stein HA, Slatt BJ, Stein RM. The Ophthalmic Assistant, Fundamentals and Clinical Practice, 5th ed. St. Louis: Mosby, 1988;424.
4. Collaborative Initial Glaucoma Treatment Study. Manual of Operations, revised March, 1997;7-22.
5. Lichter PR, Mills RP, the CIGTS Study Group. Quality of life study - determination of progression. In: Anderson DR, Drance SM, eds. Encounters in Glaucoma Research 3: How to Ascertain Progression and Outcome. Amsterdam: Kugler Publications, 1996;149-63.